ANDOVER, Mass., July 24, 2014 /PRNewswire/ -- Royal Philips
(NYSE: PHG AEX: PHIA) today announced that it has received 510(k)
clearance from the U.S. Food and Drug Administration to market its
innovative ultra mobile ultrasound system, VISIQ, in the U.S. VISIQ
is the first Philips ultrasound system to combine the benefits of
greater mobility, performance and simplicity into a single
miniaturized solution, helping clinicians increase access to
quality diagnostic scans for more OB patients.
This breakthrough ultrasound device can be easily transported
wherever care is needed, and its quick-start technology and long
battery life make it an ideal system for physician offices,
hospitals and other clinical settings.
"VISIQ marks a new vision in ultrasound for Philips by allowing
physicians to perform on-the-spot diagnostic scans, limiting the
need for patients to go to multiple locations or schedule return
visits," said Gene Saragnese, CEO,
Imaging Systems, Philips Healthcare. "VISIQ is the latest example
of Philips' continued commitment to create advanced innovative
technology solutions to deliver better care at lower cost and to
help improve patient outcomes."
VISIQ's touch-screen gesture controls are familiar to anyone who
has used a smartphone or tablet. It allows users to easily capture
images, take measurements and share data. In addition, VISIQ offers
many of the automatic image optimization features found on Philips'
premium EPIQ system, as well as built-in Wi-Fi for DICOM data
transfer to hospital or cloud-based PACS.
At the heart of the VISIQ system is a smart transducer that fits
comfortably into the user's hand. Drawing on more than 30 years of
experience in ultrasound, Philips has taken advantage of advances
in miniaturization to integrate a sophisticated broadband
micro-digital beam former and powerful image acquisition module
into the transducer. VISIQ targets OB and abdominal applications
and lays the foundation for a future range of portable ultrasound
products to meet the evolving needs of clinicians and patients.
"Portable and convenient, VISIQ is so intuitive, with
remarkable, easy-to-use measurement capabilities for maternal-fetal
medicine specialists or general obstetricians," said Dr.
Michael Ruma, maternal-fetal
medicine specialist at Perinatal Associates of New Mexico. "Instead of just listening to the
baby's heartbeat, clinicians are able to see the baby in 2D and
color."
VISIQ is also commercially available in China, East
Africa, France,
Germany and India.
For more information on VISIQ and the full suite of Philips
innovative ultrasound solutions, visit:
http://www.philips.com/VISIQ.
Contact:
Leslie
Lakis
Philips Healthcare Communications, Imaging Systems
Tel: +1 (978) 659-3748
Email: leslie.lakis@philips.com
About Royal
Philips:
Royal Philips
(NYSE: PHG, AEX: PHIA) is a diversified health and well-being
company, focused on improving people's lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and
Lighting. Headquartered in the
Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately
113,000 employees with sales and services in more than 100
countries. The company is a leader in cardiac care, acute care and
home healthcare, energy efficient lighting solutions and new
lighting applications, as well as male shaving and grooming and
oral healthcare. News from Philips is located at
www.philips.com/newscenter.
Forward-looking statements:
This release may
contain certain forward-looking statements with respect to the
financial condition, results of operations and business of Philips
and certain of the plans and objectives of Philips with respect to
these items. By their nature, forward-looking statements
involve risk and uncertainty because they relate to events and
depend on circumstances that will occur in the future and there are
many factors that could cause actual results and developments to
differ materially from those expressed or implied by these
forward-looking statements.
Video -
http://origin-qps.onstreammedia.com/origin/multivu_archive/PRNA/ENR/FX-MM75440-20140723-1.mp4
Photo - http://photos.prnewswire.com/prnh/20140723/129910
Photo - http://photos.prnewswire.com/prnh/20140723/129909
Logo - http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
SOURCE Royal Philips